HSBC raised the target price for Wuxi Bio (02269) to HKD45.8 from HKD44 and maintained the "buy" rating.
The research house said it raises 2027-28e adjusted NP estimates by 8-18%.
【你點睇？】「Save Lily」父母獲證實與男嬰有血緣關係，你認為在確認親生關係後，政府是否仍應繼續介入調查？今次事件中，社會是否對涉事父母過早作出負面判斷？ ► 立即投票
